Investment Pathways
Nathan
Member
Hi All
I wondered what if anything people have added to reports and or your investment process in relation to investment pathways?
COBS 9.3.3A
https://www.handbook.fca.org.uk/handbook/COBS/9/?date=2021-03-31&view=chapter
Thanks in advance.
Nathan
Comments
Begrudgingly, yes, when it's a client in drawdown:
Since writing my original report, the FCA has conducted a review of retirement outcomes. As a result,
from February 2021, pension providers (such as AJ Bell) are required to offer four investment
pathways to cater for four retirement objectives, allocating one pathway solution (investment
solution/fund) to each pathway. The four pathways are:
Option 1 – no plans to touch my money in the next five years
Option 2 – plan to use my money to set up a guaranteed income (annually) within the next five
years
Option 3 – plan to start taking my money as a long-term income within the next five years
Option 4 – plan to take out all my money within the next five years
These new requirements apply to non-advised clients, however, where pathway solutions are
available through an advised proposition, these need to be taken into consideration as part of any
recommendation.
AJ Bell has confirmed that they have four investment pathways available through their SIPP. Whilst
these have lower charges than BMAM, I believe that BMAM offer a superior service and investment
strategy. Please refer to my original report for further information why BMAM were originally selected.
@arongunningham that is great, thank you
Yes and no. If there is a suitable pathway I include something a little less wordy than Aron (I only cite the pathway that applies to them for example). But there is no requirement to put anything in the suitability report.
Thanks everyone for the info.
Our external compliance team are telling us we need to put something in the SR. Similar to the stakeholder consideration for pension switches. Is that true? She is quoting COBS9.2.1R(1)(a), but I am jiggered if i can find that.
Looks again the FCA have found and issue and come up with a solution that does very little to actually help clients, just another tick box on the suitability reports.
COBS 9.2 is about assessing suitability, not the content of a suitability report. There is guidance in cobs 9.3 to assess the suitability of an available investment pathway, in order to comply with 9.2.1r.
The requirements for stakeholder and WPS are in cobs 19.2.2. There is an explicit rule which says that you must explain, in the suitability report, why the recommendation is at least as suitable as those options.
You could make a case that it is worth putting into a suitability report in certain limited situations, eg if there is a suitable investment pathway option, and this is the approach I take (and hence my "yes and no" reply previously).
I'm not sure it's fair to blame the FCA for someone's misinterpretation of the rules.
Thanks Benjamin, great stuff!
Thanks all
Sorry to revive such an old conversation but I'm having precisely the issue @Redawg31 describes above, and having got a second opinion they are saying "the COBS section is guidance rather than a rule. I would suggest that this should be included in a SR where it is relevant so that the client is in an informed position to make an informed decision."
I suppose the issue is to pin down exactly where it is relevant as I'm not really very clear where it would be. Either it's relevant enough to recommend it or it's not but we don't have to put options disregarded into the suitability report, just into the suitability file? What am I missing?
Our compliance people insist that it is in every drawdown report, despite the facts that Investment Pathways are aimed at non-advised clients and that they are not available through our chosen platform.
So we have a wonderful paragraph that says that we have not recommended something that we don't have to consider recommending to them and is not available through the product that we have previously recommended to them. If we were to recommend them, we would have to make a new recommendation for a product that we have already deemed less suitable than the one we previously recommended.
Genius!
If the compliance people are saying it has to be in an SR and they throw a paragraph at you to insert just do it and have done. With regard to relevance remember that these were introduced for people who were entering income drawdown (typically accessing their PCLS). So if the client hasn't done this Investment Pathways are irrelevant. Then you look at which, if any, applies directly to the client. Clients may fall between a number of these pathways. If so then they're relevant but your advisory business' researched CIP and CRP is going to be a better solution. Also, the investment pathway that needs to be considered is the one available (if any) to the product you are advising, which you have already established as suitable on other grounds. I often find that the investment pathway that is available doesn't match the agreed risk profile, so that is relevant but quite easily dismissed because, again, the firm's researched CIP and CRP is going to be a better solution.